SCHEMBL29363132

SCHEMBL29363132

CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)OCC(O)CO)[C@H]2CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.67
▸ ALOX15 P16050 3/20 0.67
▸ PDK1 Q15118 2/20 0.67
▸ PDK2 Q15119 2/20 0.67
▸ PDK3 Q15120 2/20 0.67
▸ PDK4 Q16654 2/20 0.67
▸ LMNA P02545 2/20 0.67
▸ ALDH1A1 P00352 2/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ MAPT P10636 2/20 0.67
▸ SLCO1B3 Q9NPD5 1/20 0.67
▸ SLCO1B1 Q9Y6L6 1/20 0.67
▸ GABRA1 P14867 1/20 0.67
▸ GABRB2 P47870 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.67
▸ MAPK1 P28482 2/20 0.60
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15137271 1.00 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL123110 1.00 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL31152669 1.00 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL15072078 1.00 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
Maleic Acid SCHEMBL2119082 0.95 HSD17B10 (0.64) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL15072071 0.93 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL15076162 0.92 HSD17B10 (0.66) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL24412724 0.91 HSD17B10 (0.65) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL13454791 0.91 HSD17B10 (0.65) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL17014612 0.90 HSD17B10 (0.64) HSD17B10ALOX15PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12636251-B1 Glycoside-containing aqueous formulations having a lipophilic active component Doane Technology Group LLC (US) 2026-05-26 — — US claimed
WO-2026102051-A1 METHOD AND SYSTEM FOR STABILIZING EMULSIONS USING VITAMINS AND VITAMINS SALTS ABSTRAX TECH INC. (US) 2026-05-15 — — WO claimed
WO-2026102053-A1 FOAM ENHANCING PHOSPHOLIPID EMULSION SYSTEMS ABSTRAX TECH INC. (US) 2026-05-15 — — WO claimed
US-20260123653-A1 Foam Enhancing Phospholipid Emulsion Systems ABSTRAX TECH INC (US) 2026-05-07 — — US claimed
US-20260125625-A1 HOPS ACIDS STABILIZED EMULSIONS ABSTRAX TECH INC (US) 2026-05-07 — — US claimed
WO-2026087310-A1 COMPOSITION, CONSUMABLE AND METHODS GIVAUDAN SA (CH) 2026-04-30 — — WO claimed
US-20260114485-A1 METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF LIN JIAYOU (US) 2026-04-30 — — US claimed
WO-2026089741-A1 A METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF LIN JIAYOU (US) 2026-04-30 — — WO claimed
US-12551416-B2 Method for preparing stable liquid emulsion forms of plant extract SORSE TECHNOLOGY CORPORATION (US) 2026-02-17 — — US claimed
US-20250347498-A1 PROJECTABLE RESIN TARGET AND METHOD BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT AND COLLATERAL MAY 19, 2026 2025-11-13 — — US claimed
WO-2022120503-A1 AGRICULTURAL FORMULATION COMPRISING AT LEAST ONE BACTERIAL STRAIN B. SAFENSIS RGM 2450, AND/OR A BACTERIAL STRAIN B. SIAMENSIS RGM 2529 AND AGRICULTURAL EXCIPIENTS; USE OF THE FORMULATION AND METHOD FOR STIMULATING GROWTH AND/OR INCREASING CROP YIELDS AND/OR PROTECTING CROPS AGAINST DISEASES AND PESTS BLANES SPA (CL) 2022-06-16 — — WO claimed
CN-112812283-B Bio-based degradable polyester resin and preparation method and application thereof 北京化工大学 2022-05-20 — — CN claimed
CN-114423286-A Agrochemical formulations containing sulfopolymers 伊士曼化工公司 2022-04-29 — — CN claimed
US-20220117861-A1 METHOD FOR PREPARING STABLE LIQUID EMULSION FORMS OF PLANT EXTRACT SORSE TECH CORPORATION (US) 2022-04-21 — — US claimed
US-20220110353-A1 LIQUID CONCENTRATE DELIVERY SYSTEM FIRMENICH & CIE (CH) 2022-04-14 — — US claimed
US-11273105-B2 Method for preparing solid forms of plant extract SORSE TECHNOLOGY CORPORATION (US) 2022-03-15 — — US claimed
US-11259999-B2 Method for making toothpaste enabling enamel restoration XI'AN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-03-01 — — US claimed
WO-2022034609-A1 ENCAPSULATED CARBONYL IRON SALT COMPOSITIONS AND PROCESS THEREOF NALAWADE PRAVIN (IN) 2022-02-17 — — WO claimed
US-20220046941-A1 SILICA MICROCAPSULES AND METHODS OF PREPARING SAME INTERNATIONAL FLAVORS & FRAGRANCES INC. 2022-02-17 — — US claimed
WO-2022019686-A1 METHOD FOR PREPARING CULTURED MEAT ON BASIS OF CELL COATING TECHNIQUE, AND CULTURED MEAT PREPARED THEREBY 연세대학교 산학협력단 2022-01-27 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125625-A1 HOPS ACIDS STABILIZED EMULSIONS HAO2, NIPSNAP1, AP2S1 HSD17B10 616/4885ALOX15 1303/4885PDK1 1135/4885
US-12551416-B2 Method for preparing stable liquid emulsion forms of plant extract FABP6, LIPC, FABP2 HSD17B10 1039/4885ALOX15 49/4885PDK1 4470/4885
US-20260123653-A1 Foam Enhancing Phospholipid Emulsion Systems PHOSPHO1, PLTP, PLIN3 HSD17B10 3230/4885ALOX15 214/4885PDK1 1603/4885
US-12636251-B1 Glycoside-containing aqueous formulations having a lipophilic active component CNR2, CNR1, LIPC HSD17B10 300/4885ALOX15 483/4885PDK1 2929/4885
US-20260114485-A1 METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF NOTUM, PNLIP, ELOVL3 HSD17B10 1459/4885ALOX15 189/4885PDK1 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback